Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: a report of 2 cases.
Nancey
Stephane
S
Bouhour
Françoise
F
Boschetti
Gilles
G
Magnier
Christophe
C
Gonneau
Pierre-Marie
PM
Souquet
Jean-Christophe
JC
Kaiserlian
Dominique
D
Flourie
Bernard
B
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D016472:Motor Neuron Disease / Q000139:chemically induced* / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000188:drug therapy; D013577:Syndrome; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab